Cognex Corporation (NASDAQ:CGNX) has a beta of 1.64, a 12-month trailing P/E ratio of 61.60, and a growth ratio of 4.11. The stock’s Relative Strength Index (RSI) is 46.34, with weekly volatility at 1.86% and ATR at 1.84. The CGNX stock’s 52-week price range has touched low of $52.24 and a $101.82 high. Its shares traded lower over the last trading session, losing -1.34% on 06/03/21. The shares fell to a low of $77.5325 before closing at $77.92. Intraday shares traded counted 0.77 million, which was 0.26% higher than its 30-day average trading volume of 776.24K. CGNX’s previous close was $78.98 while the outstanding shares total 176.29M.
Investors have identified the Scientific & Technical Instruments company Cognex Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $13.55 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Cognex Corporation (CGNX) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 625.57 million total, with 159.68 million as their total liabilities.
CGNX were able to record 96.2 million as free cash flow during the 08/02/2021 quarter of the year, this saw their quarterly net cash flow reduce by -26.39 million. In cash movements, the company had a total of 98.64 million as operating cash flow.
Potential earnings growth for Cognex Corporation (CGNX)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/02/2021 quarter of the year, Cognex Corporation recorded a total of 239.03 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 30.04% coming in sequential stages and their sales for the 08/02/2021 quarter increasing by 6.45%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 54.05 million trying to sell their products during the last quarter, with the result yielding a gross income of 184.98 million. This allows shareholders to hold on to 176.29M with the recently reported earning now reading 0.40 cents per share. This is a figure that compared to analyst’s prediction for their 08/02/2021 (0.39 cents a share).
Having a look at the company’s valuation, the company is expected to record 1.67 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CGNX sounds very interesting.
Is the stock of CGNX attractive?
In related news, Director, PARROTTE DIANNE M sold 333 shares of the company’s stock in a transaction that recorded on Jun 01. The sale was performed at an average price of 80.03, for a total value of 26,651. As the sale deal closes, the Director, Schneider Jerry A. now sold 5,000 shares of the company’s stock, valued at 411,292. Also, EVP, Vision & ID Products, Gerst Carl sold 115,000 shares of the company’s stock in a deal that was recorded on Feb 23. The shares were price at an average price of 82.76 per share, with a total market value of 9,517,136. Following this completion of acquisition, the Director, PARROTTE DIANNE M now holds 9,800 shares of the company’s stock, valued at 853,226. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.20%.
5 out of 19 analysts covering the stock have rated it a Buy, while 10 have maintained a Hold recommendation on Cognex Corporation. 4 analysts has assigned a Sell rating on the CGNX stock. The 12-month mean consensus price target for the company’s shares has been set at $90.79.